Streetbeat News

Earnings

GPCR

Structure Therapeutics Inc. (NASDAQ:GPCR) announced positive 12-week results from its Phase 2a study of the obesity drug GSBR-1290, showing significant weight loss and favorable safety profiles. The capsule to tablet PK study also demonstrated promising results.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:32 am

JBLU

JetBlue has revised its Q2 revenue outlook slightly upward due to better operational performance and declining jet fuel prices. The company maintains a high completion factor of approximately 99%.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:30 am

AMC

GME

GTLB

NVDA

QQQ

SAIC

SPY

Wall Street is poised for a strong start to June, driven by a resurgence in meme stocks and positive tech sector developments. GameStop and AMC Entertainment saw significant premarket gains due to renewed interest from investors. Nvidia also rose following a keynote address at Computex 2024. Key economic data and manufacturing activity reports are expected to influence market sentiment throughout the week.

Portfolio Pulse from Shanthi Rexaline

June 03, 2024 | 11:29 am

HON

Honeywell has raised its FY24 sales outlook to $38.5B - $39.3B and adjusted EPS to $10.15 - $10.45, surpassing estimates. The company expects organic sales growth of 4% to 6%, segment margin expansion of 30 to 60 basis points, and free cash flow of $5.6B to $6.0B.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:22 am

HON

Honeywell has raised its Q2 sales outlook to $9.3B - $9.6B and adjusted EPS to $2.35 - $2.45, indicating positive growth. The company expects organic sales growth of 1% to 4% and a segment margin of 22.7% to 23.1%.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:19 am

BPTH

Bio-Path presented interim results from its Phase 2 study of Prexigebersen (BP1001) in combination with Decitabine and Venetoclax for Acute Myeloid Leukemia at the American Society of Clinical Oncology Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:12 am

SRCL

Waste Management (WM) expects its acquisition of Stericycle (SRCL) to be accretive to earnings and cash flow within one year of closing. The deal, approved by both companies' boards, is expected to close in Q4 2024. WM will finance the transaction using a combination of bank debt and senior notes.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:08 am

TLSI

TriSalus Life Sciences (NASDAQ:TLSI) presented data from its Phase 1b PERIO-02 clinical trial at the ASCO 2024 Annual Meeting. The trial focuses on using the company's Pressure Enabled Drug Delivery™ (PEDD™) technology to enhance drug delivery in liver and pancreatic cancer treatments.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:08 am

DIA

GLD

QQQ

SPY

UNG

On May 31st, the U.S. stock markets closed mixed with the Dow and S&P 500 ending higher, driven by month-end repositioning. The Federal Reserve's preferred inflation measure remained steady at 2.7% year-on-year in April 2024. Almost all sectors of the S&P 500 finished in the green, led by the energy sector, while the technology sector ended slightly down. Asian and European markets also saw gains, with notable increases in Japan's Nikkei 225 and India's Nifty 50. Commodities showed mixed results, with natural gas gaining significantly.

Portfolio Pulse from Akanksha Bakshi

June 03, 2024 | 11:03 am

SAIC

Science Applications International Corp (SAIC) has reiterated its FY25 revenue guidance of $7.35 billion to $7.50 billion, compared to the estimated $7.45 billion. The company also reaffirmed its adjusted EPS guidance of $8.00 to $8.20, versus the estimated $8.10.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 11:02 am